Cargando…
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Ischaemic stroke and systemic embolism are the major potentially preventable complications of atrial fibrillation (AF) leading to severe morbidity and mortality. Anticoagulation using vitamin K antagonists (VKA) or non-vitamin K oral anticoagulants (NOACs) is mandatory for stroke prevention in AF. F...
Autores principales: | Schäfer, Andreas, Flierl, Ulrike, Berliner, Dominik, Bauersachs, Johann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334273/ https://www.ncbi.nlm.nih.gov/pubmed/32350792 http://dx.doi.org/10.1007/s10557-020-06981-3 |
Ejemplares similares
-
Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
por: Schäfer, Andreas, et al.
Publicado: (2021) -
Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI
por: Schäfer, Andreas, et al.
Publicado: (2020) -
Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014) -
Preventing stroke in atrial fibrillation patients – clinical utility of oral anticoagulants
por: Jhawar, Manish B, et al.
Publicado: (2012) -
Oral anticoagulant use for stroke prevention in atrial fibrillation patients with difficult scenarios
por: Chang, Ting-Yung, et al.
Publicado: (2018)